Influencing the rate of progression in CKD patients is usually associated with genes polymorphisms of inflammatory response, fibrosis, metabolism, CKD progression, and renin-angiotensin-aldosterone system (RAAS) (Yan et al., 2021). The gene discussed is REN; the disease is chronic kidney disease.